Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
BMC Palliative Care
|
March 23, 2022
What are the personal last wishes of people with a life-limiting illness? Findings from a longitudinal observational study in specialist palliative care
Anneke Ullrich, Wiebke Hollburg, Holger Schulz, et al.
Urologic Oncology
|
September 9, 2019
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Psycho-Oncology
|
August 18, 2020
Efficacy of the Managing Cancer and Living Meaningfully (CALM) individual psychotherapy for patients with advanced cancer: A single-blind randomized controlled trial
Anja Mehnert, Susan Koranyi, Rebecca Philipp, et al.
Journal of Cancer Research and Clinical Oncology
|
April 4, 2014
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)
Lars Arne Berger, Carsten Bokemeyer, Anja Lorch, et al.
European Urology
|
August 7, 2016
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
BMC Palliative Care
|
May 6, 2022
Dying in hospital in Germany - optimising care in the dying phase: study protocol for a multi-centre bottom-up intervention on ward level
Kerstin Kremeike, Anneke Ullrich, Holger Schulz, et al.
Molecular Cancer Therapeutics
|
March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
Marcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
World Journal of Urology
|
September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review
Christian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
Anti-Cancer Drugs
|
May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil
Joerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Trials
|
May 7, 2026
Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU)
Rebecca Philipp, Charlotte Walbaum, Carsten Bokemeyer, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
BMC Palliative Care
|
March 23, 2022
What are the personal last wishes of people with a life-limiting illness? Findings from a longitudinal observational study in specialist palliative care
Anneke Ullrich, Wiebke Hollburg, Holger Schulz, et al.
Urologic Oncology
|
September 9, 2019
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Psycho-Oncology
|
August 18, 2020
Efficacy of the Managing Cancer and Living Meaningfully (CALM) individual psychotherapy for patients with advanced cancer: A single-blind randomized controlled trial
Anja Mehnert, Susan Koranyi, Rebecca Philipp, et al.
Journal of Cancer Research and Clinical Oncology
|
April 4, 2014
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)
Lars Arne Berger, Carsten Bokemeyer, Anja Lorch, et al.
European Urology
|
August 7, 2016
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
BMC Palliative Care
|
May 6, 2022
Dying in hospital in Germany - optimising care in the dying phase: study protocol for a multi-centre bottom-up intervention on ward level
Kerstin Kremeike, Anneke Ullrich, Holger Schulz, et al.
Molecular Cancer Therapeutics
|
March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
Marcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
World Journal of Urology
|
September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review
Christian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
Anti-Cancer Drugs
|
May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil
Joerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.
Trials
|
May 7, 2026
Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU)
Rebecca Philipp, Charlotte Walbaum, Carsten Bokemeyer, et al.
Page
of 12